FDA found cancer causing impurity in anti-diabetic medicine
FDA found out cancer causing impurity in commonly used anti-diabetic medicines, sitagliptin and notified in Drug safety report. FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 (known as NTTP), in certain samples of sitagliptin, a medicine used to treat type 2 diabetes mellitus.